经皮胆囊造口术:Seldinger与Trocar技术的比较
本研究回顾性纳入169例接受超声引导下经皮胆囊造口术的高危急性胆囊炎患者,比较Seldinger与Trocar技术的操作时间及术后疼痛等结局。结果发现Trocar技术操作时间显著更短,经腹腔路径亚组中Seldinger技术重度疼痛风险更高,但Trocar组30天粗死亡率较高,需前瞻性研究确认。
要点
- Trocar技术操作时间显著短于Seldinger技术,适合需要快速完成操作的高危患者。
- 经腹腔路径下Seldinger技术重度疼痛风险约为Trocar的7倍,选择入路时需权衡。
- Trocar组30天粗死亡率较高,可能与选择偏倚及基础病情有关,解读时需谨慎。
核心结论
- Trocar技术是Seldinger技术的一种省时替代方案。
- 当解剖上无法避免经腹腔路径时,可优先选择Trocar技术以减少操作时间和重度术后疼痛。
- 上述结论需要更大规模的前瞻性研究加以确认。
研究设计与样本
- 回顾性队列研究,纳入2020年1月至2024年8月连续169例接受超声引导经皮胆囊造口术的高危急性胆囊炎患者。
- Seldinger组130例,Trocar组39例,主要结局为操作时间,次要结局包括技术成功率、临床成功率、术后疼痛、不良事件及30天死亡率。
- 采用多变量回归并校正疾病严重度TG18分级、合并症、胆囊形态及解剖入路,敏感性分析包括逆概率加权和混杂评分校正。
关键影像表现/征象
- 所有操作均为超声引导下经皮穿刺胆囊造口,入路分为经肝路径与经腹腔路径。
- 原文未报告胆囊壁厚度、胆囊扩张程度、结石或穿孔等具体影像征象的分布与鉴别要点。
诊断标准与关键数值
- Trocar组中位操作时间为81秒(IQR 69-99),Seldinger组为246秒(IQR 199-399),调整后平均差-212.78秒(95%CI -314.68至-110.88,P<0.001)。
- 技术成功率Seldinger组99.2%对Trocar组100%,临床成功率Seldinger组98.5%对Trocar组94.9%。
- 经腹腔路径亚组中Seldinger技术重度疼痛风险为Trocar技术的7.36倍(调整后OR 7.36,95%CI 1.48至36.65,P=0.015),经肝路径亚组无差异。
- 总体阿片类药物需求两组无差异(调整后OR 1.01,P=0.97),30天粗死亡率Trocar组23.1%对Seldinger组6.2%。
临床应用与阅片要点
- 对于病情不稳定、解剖入路困难或需要迅速完成胆道减压者,可优先考虑Trocar技术以缩短操作时间。
- 当计划采用经腹腔路径时,Trocar技术可能减少术后重度疼痛,降低强阿片类药物使用需求。
- 阅片或术前规划时应关注胆囊与肝实质的位置关系,评估经肝路径的可行性,以帮助临床选择穿刺技术。
局限性
- 回顾性单中心设计可能存在选择偏倚,尤其是病情不稳定者可能被倾向性分配至更快的Trocar技术组。
- Trocar组样本量较小,且30天粗死亡率差异可能与非胆道脓毒症及基础合并症有关,而非操作相关事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare procedural time (primary outcome) and technical success, clinical success, post-procedural pain and safety outcomes between the Seldinger and Trocar techniques for percutaneous cholecystostomy (PC) in high-risk patients with acute cholecystitis.
MATERIALS AND METHODS: This retrospective cohort study included 169 consecutive patients (Seldinger: n = 130; Trocar: n = 39) who underwent ultrasound-guided PC between January 2020 and August 2024. The primary outcome was procedural time. Secondary outcomes were technical and clinical success, post-procedural pain (defined as the requirement for strong [WHO Step-3] opioid analgesics), adverse events graded per the Society of Interventional Radiology (SIR) Adverse Event Classification, and 30-day mortality. Multivariable regression with marginalization was used to estimate adjusted associations between technique and outcome, adjusting for disease severity (TG18 grade), comorbidities, gallbladder morphology, and anatomical approach (transhepatic vs. transperitoneal). Inverse-probability-of-treatment weighting and confounder-score adjustment were performed as sensitivity analyses.
RESULTS: The Trocar technique was significantly faster (median procedural time 81 s [IQR 69-99] vs. 246 s [IQR 199-399]; adjusted mean difference -212.78 s; 95% CI -314.68, - 110.88; p < 0.001). Both techniques achieved high technical (99.2% vs. 100%) and clinical success rates (98.5% vs. 94.9%). Overall opioid requirement did not differ between techniques (adjusted OR 1.01; p = 0.97). A significant interaction (effect modification) was observed between technique and access route: in the transperitoneal subgroup the Seldinger technique was associated with a 7-fold higher risk of severe pain than the Trocar technique (adjusted OR 7.36; 95% CI: 1.48, 36.65; p = 0.015), whereas no difference was found in the transhepatic subgroup. The 30-day crude mortality rate was higher in the Trocar group (23.1% vs. 6.2%); cause-specific adjudication suggested that the excess deaths were attributable to non-biliary sepsis and underlying comorbidities rather than procedure-related events, although residual selection bias toward use of the faster technique in unstable patients cannot be excluded.
CONCLUSION: The Trocar technique is a time-efficient alternative to the Seldinger technique for percutaneous cholecystostomy. Our findings suggest that, when transperitoneal access is anatomically unavoidable, the Trocar technique may be preferred to reduce procedural time and severe post-procedural pain. Confirmation in larger prospective studies is warranted.
引用
- Nimitrungtawee, Thawang, Phinyo, et al. Seldinger versus Trocar technique for percutaneous cholecystostomy: impact of access route on procedural time and post-procedural pain. Abdom Radiol (NY). 2026. PMID: 42334600. doi:10.1007/s00261-026-05585-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。